Medicare Enrolled
Dr. Gregory Oleyourryk, MD
Urology Physician · Rochester, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Oleyourryk from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Oleyourryk?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Oleyourryk
Dr. Gregory Oleyourryk is an urology physician in Rochester, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Oleyourryk performed 1,418 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Oleyourryk received a total of $9,384 from 62 pharmaceutical and/or device companies across 479 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Oleyourryk is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 43% volume in NY
$9,384 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,418
Medicare services
Top 43% in NY for urology physician
Not available
Unique patients (not deduplicated)
$54
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
424 | $62 | $117 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
384 | $4 | $5 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
109 | $90 | $172 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
89 | $7 | $30 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 84 | $130 | $251 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
68 | $21 | $28 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
67 | $169 | $328 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
48 | $74 | $176 |
| Simple change of bladder tube | 30 | $73 | $146 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
28 | $45 | $112 |
| Insertion of temporary bladder tube | 23 | $33 | $87 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
17 | $26 | $63 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
14 | $249 | $391 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
11 | $181 | $350 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
11 | $107 | $150 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
11 | $0 | $1 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
1.0% high complexity
9.8% medium
89.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,384
Total received (2018-2024)
Avg $1,341/year across 7 years
Top 19% in NY for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
62
Companies
479
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,365
2023
$1,917
2022
$1,304
2021
$626
2020
$1,054
2019
$1,097
2018
$1,022
Payments by company (2024)
Sumitomo Pharma America, Inc.
$430
Dendreon Pharmaceuticals LLC
$382
Janssen Biotech, Inc.
$276
ABBVIE INC.
$144
Ferring Pharmaceuticals Inc.
$123
Myriad Genetic Laboratories, Inc.
$108
PFIZER INC.
$103
COLOPLAST CORP
$91
Calyxo, Inc.
$81
UROGEN PHARMA, INC.
$79
Teleflex LLC
$69
Merck Sharp & Dohme LLC
$68
PROCEPT BioRobotics Corporation
$67
Blue Earth Diagnostics Limited
$66
C. R. Bard, Inc. & Subsidiaries
$65
Novo Nordisk Inc
$53
Cook Medical LLC
$33
Antares Pharma, Inc.
$26
Medtronic, Inc.
$24
ACCORD HEALTHCARE, INC.
$24
Astellas Pharma US Inc
$19
Olympus America Inc.
$18
IMMUNITYBIO, INC.
$18
Top 3 companies account for 46.0% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$1,721
Astellas Pharma US Inc
$1,022
Dendreon Pharmaceuticals LLC
$750
Sumitomo Pharma America, Inc.
$710
PFIZER INC.
$537
Antares Pharma, Inc.
$324
ABBVIE INC.
$266
NeoTract Inc.
$252
Ferring Pharmaceuticals Inc.
$201
Teleflex LLC
$198
Merck Sharp & Dohme LLC
$193
PROCEPT BioRobotics Corporation
$180
180 Medical, Inc.
$180
UroGen Pharma, Inc.
$173
TOLMAR Pharmaceuticals, Inc.
$172
Coloplast Corp
$168
Allergan Inc.
$158
UROVANT SCIENCES INC
$149
Myriad Genetic Laboratories, Inc.
$123
Medtronic USA, Inc.
$110
C. R. Bard, Inc. & Subsidiaries
$101
Bayer HealthCare Pharmaceuticals Inc.
$93
COLOPLAST CORP
$91
Endo Pharmaceuticals Inc.
$89
Medtronic, Inc.
$84
Calyxo, Inc.
$81
UROGEN PHARMA, INC.
$79
Mission Pharmacal Company
$77
AbbVie, Inc.
$69
Blue Earth Diagnostics Limited
$66
TISSUETECH, INC.
$60
Merck Sharp & Dohme Corporation
$58
Olympus America Inc.
$53
Novo Nordisk Inc
$53
AbbVie Inc.
$50
Cook Medical LLC
$44
ACCORD HEALTHCARE, INC.
$44
Telix Pharmaceuticals
$41
Zyla Life Sciences, Inc.
$38
Tolmar, Inc.
$37
Clarus Therapeutics Inc.
$37
Amgen Inc.
$34
Allergan, Inc.
$31
ROCHESTER MEDICAL CORPORATION
$30
Foundation Medicine, Inc.
$30
Mallinckrodt LLC
$29
Janssen Pharmaceuticals, Inc
$27
Ambu Inc.
$26
Avadel Specialty Pharmaceuticals, LLC
$25
Novartis Pharmaceuticals Corporation
$23
Progenics Pharmaceuticals, Inc.
$21
Retrophin, Inc.
$21
Teleflex Medical Incorporated
$20
TherapeuticsMD, Inc.
$19
IMMUNITYBIO, INC.
$18
Amniox Medical, Inc.
$17
Zyla Life Sciences
$17
NxThera, Inc.
$15
Myovant Sciences Inc.
$14
BioTissue Holdings, Inc.
$14
BOSTON SCIENTIFIC CORPORATION
$12
Sagent Pharmaceuticals, Inc.
$11
Top 3 companies account for 37.2% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · AFINITOR · ANKTIVA · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · Access Solutions: Weck brand · Androgel · AquaBeam Robotic System · BOTOX · BOTOX THERAPEUTIC · BRACANALYSIS CDX · Balversa · Bard Urinary Drainage Bag · Brava · CAMCEVI · CURE CATHETER · CVAC ASPIRATION SYSTEM · Cook Medical Dilation/Access · EDEX · ELIGARD · ERLEADA · Erleada · FIRMAGON · FOUNDATIONONE · GEMTESA · GENERAL BPH · GENTLECATH · GENTLECATH GLIDE · Glydo · ILLUCCIX · IMVEXXY · INTERSTIM · JATENZO · JELMYTO · KEYTRUDA · LITHO 150 · LUPRON DEPOT · LYNPARZA · Lupron · MYRBETRIQ · Myrbetriq · NEOX · NOCDURNA · Noctiva · OFIRMEV · ORGOVYX · OTREXUP · Otrexup · POSLUMA · PROKERA · PROLARIS · PROVENGE · PYLARIFY · Prolia · Rezum · Rivfloza · SKYLITE · SPEEDICATH · SPRIX · SpeediCath · TITAN · TOVIAZ · UROLIFT · Uribel · UroLift · UroLift System · Urocit-K · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · iTIND System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
40
County median income
$74,409
Nearest hospital to ZIP centroid (approximate)
ROCHESTER GENERAL HOSPITAL
2.8 mi
2.8 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Oleyourryk is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Oleyourryk experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Oleyourryk performed 424 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Oleyourryk receive payments from pharmaceutical companies?
Yes. Dr. Oleyourryk received a total of $9,384 from 62 companies across 479 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Oleyourryk's costs compare to other urology physicians in Rochester?
Dr. Oleyourryk's average Medicare payment per service is $54. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Oleyourryk) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Rochester
Browse urology physicians in Rochester ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NY
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NY
Which NY urology physicians receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology